Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies ; volume:38 ; number:2 ; day:23 ; month:1 ; year:2024 ; pages:205-226 ; date:3.2024
BioDrugs ; 38, Heft 2 (23.1.2024), 205-226, 3.2024
- Creator
-
Harris, Chantal T.
Cohen, Sivan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-023-00641-2
- URN
-
urn:nbn:de:101:1-2405101047270.244922989605
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 12:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Harris, Chantal T.
- Cohen, Sivan
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework
Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies
Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
Reducing organ immunogenicity during ex vivo machine perfusion
Immunogenicity of Biopharmaceuticals
Immunogenicity of autoantigens
Immunogenicity of Extracellular Vesicles
Immunogenicity of botulinum toxin
Optogenetic Peripheral Nerve Immunogenicity
Immunogenicity of botulinum toxins
Population pharmacokinetic modelling and simulation of monoclonal antibodies including the impact of immunogenicity and importance of study and analysis design factors
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework
Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies
Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
Reducing organ immunogenicity during ex vivo machine perfusion
Immunogenicity of Biopharmaceuticals
Immunogenicity of autoantigens
Immunogenicity of Extracellular Vesicles
Immunogenicity of botulinum toxin
Optogenetic Peripheral Nerve Immunogenicity
Immunogenicity of botulinum toxins
Population pharmacokinetic modelling and simulation of monoclonal antibodies including the impact of immunogenicity and importance of study and analysis design factors
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework
Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies
Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
Reducing organ immunogenicity during ex vivo machine perfusion
Immunogenicity of Biopharmaceuticals
Immunogenicity of autoantigens
Immunogenicity of Extracellular Vesicles
Immunogenicity of botulinum toxin
Optogenetic Peripheral Nerve Immunogenicity
Immunogenicity of botulinum toxins